FathomX is a MedTech AI startup based in Singapore that specializes in developing technologies for women's health. Founded in 2019, the company's primary focus is on deploying clinician-friendly solutions to enhance existing workflows in the medical sector, with its first project targeting public health and aiming to enhance breast cancer screening with AI. The breakthrough AI solution has been noted for significantly reducing false positive rates by 80% and streamlining the clinical workflow by cutting down clinician numbers by 50%.
Their remarkable achievements have been recognized in esteemed publications such as JAMA Open Network and AAAI Workshop. Moreover, FathomX collaborates closely with global solutions provider HP Enterprise to develop a range of advanced technologies in the field of medical imaging. The company has successfully integrated its AI engines into a scalable and customizable technical infrastructure, which has already been tested in various hospitals and clinics.
The most recent investment came in the form of a grant investment on 06 June 2023, however, specific information regarding the investors involved in this latest funding round is not available at this time. FathomX demonstrates great potential in revolutionizing women's health technologies and has shown promising advancements in the MedTech AI space.
